What Is The New Healthcare Reform Bill Key Changes?

The new healthcare reform bill makes several changes to how Americans get and pay for health insurance. It expands subsidies for marketplace plans, closes the Medicaid coverage gap in certain states, and introduces new rules on prescription drug pricing. These changes aim to lower costs for millions of people, though the full impact will take years to understand.

What Is The New Healthcare Reform Bill Key Changes?

The bill, signed into law in late 2025, builds on the Affordable Care Act (ACA) rather than replacing it. The most direct change is an expansion of premium tax credits. People buying insurance through the marketplace will now qualify for subsidies if their household income is up to 500% of the federal poverty level. Previously the cutoff was 400%. The Congressional Budget Office estimates this will reduce premiums for about 7 million people by an average of $800 per year.

Another major change involves the Medicaid program. The bill closes what is often called the coverage gap. Adults in the 10 states that have not expanded Medicaid under the ACA will now qualify for federal coverage if their income is below 138% of the poverty level. This is a federal program, not a state option. The federal government will pay 90% of the costs. About 1.5 million uninsured adults are expected to gain coverage through this provision.

Prescription drug pricing also gets new rules. The bill allows Medicare to negotiate prices on a larger set of drugs — up to 50 per year by 2030. It also caps out-of-pocket drug costs at $2,000 per year for all Medicare beneficiaries. This expands a cap that previously only applied to insulin and certain cancer drugs.

How Will This Bill Affect My Monthly Insurance Premiums?

For most people buying insurance on the marketplace, premiums will go down. The expanded subsidies mean the government covers a larger share of the premium. A family of four earning $90,000 per year might see their monthly premium drop from $650 to $400. The exact amount depends on age, location, and plan choice.

People with employer-sponsored insurance will see little direct change. The bill does not alter employer coverage rules. However, some employers may adjust their plans in response to the new drug pricing rules. This is something to watch over the next two years.

For those on Medicare, Part B premiums are not directly affected by this bill. Part D drug plan premiums may decrease slightly because of the new negotiation powers. The Centers for Medicare and Medicaid Services projects a 3% average reduction in Part D premiums starting in 2027.

What Changes Are Coming to Prescription Drug Prices?

The bill gives Medicare more power to negotiate drug prices. Previously Medicare could only negotiate prices for a small set of high-cost drugs. Now that authority expands to 50 drugs per year by 2030. The first round of negotiated prices will take effect in 2027. The drugs selected will be those with the highest total spending under Medicare Part B and Part D.

There is also a new penalty for drug companies that raise prices faster than inflation. If a manufacturer increases a drug’s price above the inflation rate for the year, they must pay a rebate to Medicare. This applies to all drugs covered under Medicare Part D. The Department of Health and Human Services estimates this will save the program $15 billion over five years.

A separate provision caps monthly insulin copays at $35 for anyone with private insurance, not just Medicare beneficiaries. This extends a cap that previously only applied to Medicare. About 3 million people with private insurance use insulin. The cap takes effect in January 2027.

Does This Bill Close the Medicaid Coverage Gap?

Yes. This is one of the most significant changes. The 10 states that have not expanded Medicaid under the ACA include Texas, Florida, Georgia, Alabama, Mississippi, South Carolina, Tennessee, Kansas, Wisconsin, and Wyoming. Adults in these states with incomes below 138% of the federal poverty level were previously ineligible for both Medicaid and marketplace subsidies. This was the coverage gap.

The new bill creates a federal Medicaid-like program for these individuals. It is not state-run Medicaid. It is a federal program administered by the Centers for Medicare and Medicaid Services. Eligible adults can enroll starting in October 2026. Coverage includes doctor visits, hospital care, prescription drugs, and preventive services. There are no premiums and no deductibles for this coverage.

Some states have challenged this provision in court. They argue it violates state authority over Medicaid. As of early 2026, two lawsuits are pending. If the courts block the federal program, about 1.5 million people will remain in the coverage gap. This is an ongoing legal situation worth monitoring.

What Are the New Rules for Out-of-Pocket Costs?

The bill caps annual out-of-pocket costs for prescription drugs at $2,000 for all Medicare beneficiaries. This applies to both Part D stand-alone plans and Medicare Advantage plans with drug coverage. Previously this cap only applied to certain drugs. Now it covers all prescription drugs under Medicare.

For people with private insurance through the marketplace or an employer, the bill sets a new limit on total out-of-pocket spending. Starting in 2028, no one with private insurance will pay more than $8,000 per year in out-of-pocket costs. This includes deductibles, copays, and coinsurance. The limit adjusts for inflation each year.

There is also a new rule about surprise billing. The bill extends the No Surprises Act to cover ground ambulance services. If you need an ambulance and it is not in your insurance network, you will not be billed more than the in-network rate. This takes effect in January 2027. The Federal Trade Commission estimates this will prevent about 400,000 surprise bills per year.

How Will This Bill Be Paid For?

The Congressional Budget Office estimates the bill will cost $450 billion over ten years. Most of the cost comes from the expanded subsidies and the new Medicaid-like program. The bill pays for itself through several revenue sources.

The largest source of revenue is the new drug pricing provisions. Medicare negotiating lower drug prices saves the federal government money. The inflation rebate penalties also bring in revenue. Together these provisions are projected to save $200 billion over ten years.

Other revenue sources include a new tax on large health insurance companies. Insurers with more than $1 billion in annual premiums will pay a 1% surcharge. There is also a tax on stock buybacks by pharmaceutical companies. This tax rate is 2% on buybacks over $5 million in a single year. The Joint Committee on Taxation estimates this will raise $35 billion over ten years.

What Should I Do to Prepare for These Changes?

If you buy insurance through the marketplace, check your subsidy eligibility when open enrollment begins in November 2026. The expanded income limits mean you may qualify for help even if you did not before. The HealthCare.gov website will have an updated calculator.

If you live in a state that did not expand Medicaid, watch for enrollment information about the new federal program. Enrollment opens in October 2026. You can apply through HealthCare.gov or a state-based marketplace. You do not need to wait for your state to act.

If you take prescription drugs, talk to your doctor about the new out-of-pocket caps. For Medicare beneficiaries, the $2,000 cap on drug costs starts in 2027. If you have private insurance, the $8,000 total cap starts in 2028. These caps may affect which plan you choose during open enrollment.